SCHEMBL4116079

SCHEMBL4116079

Cc1cc(Nc2cc(S(C)(=O)=O)nc(Cl)n2)n[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAK4 O96013 2/20 0.48
▸ PLK4 O00444 1/20 0.48
▸ MEN1 O00255 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ PIK3C3 Q8NEB9 3/20 0.41
▸ GSK3B P49841 2/20 0.41
▸ ITK Q08881 1/20 0.39
▸ AURKA O14965 10/20 0.38
▸ AURKB Q96GD4 5/20 0.38
▸ DAPK3 O43293 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ CSF1R P07333 1/20 0.38
▸ RET P07949 1/20 0.38
▸ IGF1R P08069 1/20 0.38
▸ PDGFRB P09619 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220647 0.80 PAK4 (0.57) PAK4PLK4MEN1HTTKMT2A
SCHEMBL343410 0.80 PAK4 (0.54) PAK4PLK4MEN1HTTKMT2A
SCHEMBL12102888 0.78 GSK3B (0.50) PAK4PLK4MEN1HTTKMT2A
SCHEMBL219709 0.77 PAK4 (0.43) PAK4PLK4MEN1HTTKMT2A
SCHEMBL3993234 0.75 PAK4 (0.49) PAK4PLK4MEN1HTTKMT2A
SCHEMBL22079284 0.75 PAK4 (0.49) PAK4PLK4MEN1HTTKMT2A
SCHEMBL4788903 0.75 PAK4 (0.49) PAK4PLK4MEN1HTTKMT2A
SCHEMBL3852266 0.75 DAO (0.47) PAK4PLK4MEN1HTTKMT2A
SCHEMBL24350501 0.74 PIK3C3 (0.54) PAK4PLK4MEN1HTTKMT2A
SCHEMBL20943748 0.74 SYK (0.47) PAK4PLK4MEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869032-B8 PYRIMIDINE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2009-03-25 — — EP disclosed
EP-1869032-A1 PYRIMIDINE DERIVATIVES FOR USE AS ANTICANCER AGENTS AstraZeneca AB (SE) 2007-12-26 — — EP disclosed
WO-2006106307-A1 PYRIMIDINE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2006-10-12 — — WO disclosed
Send feedback